Am J Health-Syst Pharm
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


American Journal of Health-System Pharmacy, Vol. 63, Issue 21, 2123-2127
Copyright © 2006 by American Society of Health-System Pharmacists
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bennett, R. E.
Right arrow Articles by Lauderdale, S. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bennett, R. E.
Right arrow Articles by Lauderdale, S. A.

Practice Reports

Survey of care provided by ambulatory care pharmacists to patients with chronic kidney disease

Robin E. Bennett, Renee M. DeHart and Stacy A. Lauderdale

ROBINE. BENNETT, PHARM.D., is Pharmacy Manager, Harris Teeter Pharmacy, Nashville, TN; at the time of the study she was a Pharm.D. degree candidate, McWhorter School of Pharmacy (MSP), Samford University (SU), Birmingham, AL. RENEE M. DEHART, PHARM.D., BCPS, is Professor of Pharmacy Practice and Clinical Pharmacy Specialist, MSP, SU; and is Clinical Pharmacy Specialist, Medical Center East Family Practice Residency Program, Birmingham. STACYA. LAUDERDALE, PHARM.D., is Assistant Professor of Pharmacy Practice and Drug Information Specialist, MSP, SU.

Address correspondence to Dr. DeHart at the McWhorter School of Pharmacy, Samford University, 800 Lakeshore Drive, Birmingham, AL 35229 (rmdehart{at}samford.edu).


Purpose. A survey was conducted to determine the role of ambulatory care pharmacists in the care of patients with chronic kidney disease (CKD).

Methods. Data from a survey of ambulatory care pharmacists in the treatment and management of patients with CKD were collected. A 22-item anonymous survey was sent to 1028 potential respondents in January 2004. Only pharmacists indicating routine provision of care to patients with risk factors for the development of CKD or with stages 1–4 of CKD were included in the analysis. Additional questions surveyed the timeliness and frequency of nephrology referrals and the pharmacists’ familiarity with National Kidney Foundation Kidney Disease Outcomes Quality Initiative (NKF-K/DOQI) guidelines.

Results. Of 1028 surveys, 535 were completed and returned. Only respondents who provided care in an outpatient setting to geriatric patients and patients with diabetes mellitus, hypertension, or decreased creatinine clearance were included in the analysis (n = 388). Initial assessment of CKD was performed by 85% of the surveyed pharmacists. Over one third of the pharmacists made nephrology referrals. However, even pharmacists who had a high percentage of patients with a known risk for CKD infrequently screened for kidney dysfunction, and only a small portion monitored the areas recommended by NFK-K/DOQI. The respondents’ familiarity with the NFK-K/DOQI guidelines indicated that 7% were very familiar, 45% were somewhat familiar, 34% were not very familiar, 13% were not at all familiar, and 1% did not respond.

Conclusion. The ambulatory care pharmacists surveyed were not consistently involved in the routine monitoring of common complications of CKD.

Index terms: Ambulatory care; Data collection; Diabetes mellitus; Geriatrics; Guidelines; Hypertension; Interventions; Kidney diseases; National Kidney Foundation; Pharmaceutical services; Pharmacists

 






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American Society of Health-System Pharmacists.